Meningococcal infection

AB1_MENINGOCOCCAL

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — A39 Hospital discharge: ICD-9 — 03[6] Hospital discharge: ICD-8 — 03[6] Cause of death: ICD-10 — A39 Cause of death: ICD-9 — 03[6] Cause of death: ICD-8 — 03[6] 2 out of 7 registries used, show all original rules.	323
4. Check minimum number of events None	323
5. Include endpoints None	323
6. Filter based on genotype QC (FinnGen only)	288

Control definitions (FinnGen only)

Control exclude: AB1_OTHER_BACTERIAL

Extra metadata

Level in the ICD hierarchy: 3
First used in FinnGen datafreeze: DF5

NAME	AB1_MENINGOCOCCAL
CONTROL_EXCLUDE	AB1_OTHER_BACTERIAL
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	A39
HD_ICD_9	03[6]
HD_ICD_8	03[6]
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	A39
COD_ICD_9	03[6]
COD_ICD_8	03[6]
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO
CANC_TOPO_EXCL
CANC_MORPH
CANC_MORPH_EXCL
CANC_BEHAV

Similar endpoints

↥

List of similar endpoints to Meningococcal infection based on the number of shared cases.

Similar with more cases:

Similar with less cases:

None

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

	All	Female	Male
Number of individuals
Whole population	3391	1544	1828
Only index persons	2683	1246	1437
Unadjusted period prevalence (%)
Whole population	0.05	0.04	0.05
Only index persons	0.05	0.05	0.05
Median age at first event (years)
Whole population	17.73	17.89	17.27
Only index persons	16.06	16.30	15.85

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	288	163	125
Unadjusted period prevalence (%)	0.06	0.06	0.06
Median age at first event (years)	18.26	17.92	18.71

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

No data

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
300: Matched controls
3000

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

03600

ICD-8 Finland

Meningococcal infection, Meningococcal meningitis

+∞

123.7

110

G01*A39.0

ICD-10 Finland

Meningococcal meningitis

+∞

46.0

0360A

ICD-9 Finland

Meningococcal infection, Meningococcal meningitis

+∞

32.9

A39.2

ICD-10 Finland

Acute meningococcaemia

+∞

26.4

G00.9

ICD-10 Finland

Bacterial meningitis, unspecified

118.3

20.9

A49.9

ICD-10 Finland

Bacterial infection, unspecified

19.6

18.1

A39.0

ICD-10 Finland

Meningococcal meningitis

+∞

15.8

03697

ICD-8 Finland

Meningococcal infection, Suspecta

+∞

15.8

A39.9

ICD-10 Finland

Meningococcal infection, unspecified

+∞

14.7

03610

ICD-8 Finland

Meningococcal infection, Meningococcaemia acuta sive non definita

+∞

13.6

A41.9

ICD-10 Finland

Sepsis, unspecified

135.4

12.5

Z2446

NOMESCO Finland

Social worker

4.0

10.9

A46

ICD-10 Finland

Erysipelas

4.2

10.9

0362A

ICD-9 Finland

Meningococcal infection, Meningococcaemia

+∞

8.4

A41.8

ICD-10 Finland

Other specified sepsis

+∞

8.4

G03.9

ICD-10 Finland

Meningitis, unspecified

46.2

7.8

WX730

NOMESCO Finland

Conventional respirator

14.2

6.9

111

Kela drug reimbursment

Epilepsy and comparable convulsive disorders

3.6

6.4

I70.2

ICD-10 Finland

Atherosclerosis of arteries of extremities

3.4

6.3

A39.8

ICD-10 Finland

Other meningococcal infections

+∞

6.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.5

6.2

185

N06AB04

ATC

citalopram; systemic

2.1

6.2

369

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(3023368) Bacteria identified in Blood by Culture

465

2.02

6.31

5.2

2.9

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

2.87

5.42

1.8

1.5

—

(3016293) Bicarbonate [Moles/volume] in Serum or Plasma

113

2.63

4.96

14.3

7.3

25.77

24.62

mmol/l

0.74

113

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

291

2.04

4.93

1.7

1.6

—

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

10.20

4.03

1.4

1.1

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

6.59

4.01

1.6

1.2

—

(3044290) Cell count panel - Cerebral spinal fluid

3.19

3.41

1.4

1.1

—

(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy

8.71

3.27

1.2

1.3

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

341

1.75

3.25

3.5

2.9

0.80

0.82

mmol/l

0.42

326

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

219

1.90

3.16

1.8

1.5

—

(3002030) Lymphocytes/Leukocytes in Blood

148

1174

1.51

3.13

7.1

5.7

28.54

28.92

0.13

140

1124

(3014007) Fractional oxyhemoglobin in Arterial blood

120

2.18

3.08

16.8

11.0

91.54

93.52

0.47

120

(3024891) Influenza virus A+B Ag [Presence] in Specimen

2.46

2.95

1.2

—

(3026493) Urate [Moles/volume] in Serum or Plasma

598

1.56

2.88

2.5

2.3

327.61

339.12

umol/l

0.52

537

(3019069) Monocytes/Leukocytes in Blood

143

1144

1.48

2.81

7.1

5.8

8.33

8.71

0.98

134

1087

(3016018) Differential panel - Cerebral spinal fluid

4.00

2.79

1.3

1.0

—

(3032080) INR in Blood by Coagulation assay

119

928

1.47

2.62

12.7

10.4

1.21

1.16

inr

0.35

762

(3045788) Cell count panel - Pleural fluid

4.75

2.61

1.3

1.4

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.24

2.56

1.4

1.3

—

(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

7.24

2.56

1.4

1.1

—

(3006504) Eosinophils/Leukocytes in Blood

141

1143

1.44

2.50

7.2

5.7

3.00

2.87

0.23

132

1081

(3033658) Prothrombin time (PT) actual/Normal

573

1.51

2.46

4.7

3.4

96.34

94.50

0.30

564

(3023183) Ammonium ion [Moles/volume] in Plasma

3.20

2.46

1.2

2.0

29.10

36.81

umol/l

—

(3022096) Basophils/Leukocytes in Blood

141

1146

1.43

2.45

7.2

5.7

0.63

0.72

1.22

131

1076

(3006217) Methemoglobin/Hemoglobin.total in Arterial blood

118

2.03

2.43

17.9

11.1

0.55

0.68

1.17

118

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

217

1.75

2.35

1.9

1.6

—

(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection

3.54

2.28

1.8

1.6

—

(3018010) Neutrophils/Leukocytes in Blood

141

1163

1.40

2.18

7.1

5.6

56.52

56.64

0.04

136

1117

(3028653) Carboxyhemoglobin/Hemoglobin.total in Arterial blood

123

1.94

2.18

18.1

10.6

1.56

1.49

0.08

123

(4198724) Urine methamphetamine measurement

4.35

2.16

1.5

1.1

—

(3000991) Gas panel - Venous blood

177

1.77

2.12

15.4

8.3

—

(3022313) Gas panel - Capillary blood

2.11

2.05

5.5

2.6

—

(42870588) Differential panel, method unspecified - Blood

100

785

1.41

2.03

7.3

5.6

—

(3019198) Lymphocytes [#/volume] in Blood

152

1282

1.38

2.01

6.9

5.7

2.00

1.88

e9/l

0.72

124

1129

(3024561) Albumin [Mass/volume] in Serum or Plasma

121

986

1.38

1.96

4.4

3.9

35.47

37.24

g/l

1.87

107

938

(3028707) Methadone [Presence] in Urine by Screen method

2.17

1.95

1.9

1.5

—

(3044640) Blood type and Crossmatch panel - Blood

710

1.40

1.90

2.2

1.9

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

200

1.67

1.86

3.0

2.7

—

(40768806) Pleura Pathology biopsy report

3.58

1.84

1.2

1.7

—

(3035999) Lactate [Moles/volume] in Cerebral spinal fluid

4.22

1.83

1.2

1.3

7.28

1.74

mmol/l

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

404

0.58

1.82

1.3

1.6

—

(3007853) Bacteria identified in Skin by Aerobe culture

250

1.60

1.82

1.6

1.5

—

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

526

1.43

1.80

2.1

1.9

—

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

674

0.67

1.76

1.4

1.3

0.64

1.71

u/ml

1.01

191

(3021788) Differential panel - Synovial fluid

2.71

1.73

2.3

1.3

—

(3016244) Insulin [Units/volume] in Serum or Plasma

3.89

1.72

3.8

3.3

22.42

16.35

mu/l

—

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

540

1.41

1.70

1.7

1.33

1.12

mg/l

0.25

411

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

2.23

1.69

1.1

—

(3001604) Monocytes [#/volume] in Blood

147

1256

1.33

1.69

7.2

5.7

0.58

0.55

e9/l

0.66

120

1084

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

2.55

1.68

2.0

1.4

—

(3023520) Reticulocytes [#/volume] in Blood

143

1.74

1.67

2.2

2.7

70.78

70.50

e9/l

0.01

(3006315) Basophils [#/volume] in Blood

147

1259

1.33

1.65

7.2

5.7

0.04

e9/l

0.38

119

1087

(3019977) pH of Arterial blood

210

1.59

1.56

14.0

8.0

7.43

7.42

0.21

117

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

260

1.53

1.55

5.4

4.5

29.07

30.93

0.68

180

(3013115) Eosinophils [#/volume] in Blood

150

1298

1.31

1.53

7.2

5.9

0.20

0.19

e9/l

0.32

123

1137

(3006184) Hemoglobin [Mass/volume] in Capillary blood

0.00

1.53

0.0

2.0

—

133.55

—

(4146454) Self-monitoring of blood glucose

3.37

1.53

4.0

2.9

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

2.63

1.52

1.1

1.2

—

(3003740) Influenza virus B Ag [Presence] in Specimen

2.11

1.51

1.0

1.1

—

(3002523) Influenza virus A Ag [Presence] in Specimen

2.11

1.51

1.0

1.1

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

2.41

1.47

1.6

1.2

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

2.41

1.47

1.6

1.2

—

(3044941) Cell count panel - Synovial fluid

2.41

1.47

1.4

1.2

—

(3023410) Appearance of Cerebral spinal fluid

2.53

1.46

1.6

1.1

—

(3021589) Normoblasts [#/volume] in Blood

130

1110

1.30

1.44

9.8

9.5

0.00

e9/l

0.66

908

(3019225) pH of Specimen

174

1.61

1.43

5.1

3.8

7.32

7.36

0.27

125

(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay

2.04

1.40

2.1

2.6

4.57

3.28

g/l

1.83

(3013290) Carbon dioxide [Partial pressure] in Blood

2.45

1.40

4.1

2.1

5.26

4.78

kpa

—

(3027315) Oxygen [Partial pressure] in Blood

2.45

1.40

4.1

2.1

7.94

9.29

kpa

—

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

117

989

1.30

1.39

9.5

5.1

1.21

1.22

mmol/l

0.72

102

909

(3012441) Differential panel - Pleural fluid

2.97

1.36

1.2

1.4

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

226

1.52

1.36

4.8

5.9

—

(3018572) Chloride [Moles/volume] in Blood

0.00

1.33

0.0

3.5

—

105.53

—

(3039000) Anion gap in Blood by calculation

0.00

1.33

0.0

3.5

—

10.88

—

(3016502) Oxygen saturation in Arterial blood

186

1.56

1.32

15.1

8.6

94.72

95.74

0.47

180

(3015377) Calcium [Moles/volume] in Serum or Plasma

779

1.30

1.28

3.4

2.8

2.37

2.36

mmol/l

0.27

723

(3013650) Neutrophils [#/volume] in Blood by Automated count

157

1389

1.27

1.28

9.7

8.3

4.09

3.91

e9/l

0.49

132

1202

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

2.08

1.23

1.4

2.4

—

(3012544) pH of Venous blood

198

1.51

1.22

3.0

2.5

7.38

7.39

0.68

106

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

2.19

1.22

1.0

1.1

—

(1761868) Lipid panel - Serum or Plasma

100

1171

0.78

1.21

2.7

2.9

—

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

2.33

1.19

1.0

1.5

—

(3002173) Hemoglobin [Mass/volume] in Arterial blood

183

1.52

1.18

15.6

7.4

128.00

125.38

g/l

0.28

177

(3019309) Folate [Moles/volume] in Red Blood Cells

295

1.41

1.16

1.7

1.6

1140.41

1171.27

nmol/l

0.07

230

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

1123

0.79

1.14

1.8

1.9

1.50

1.42

mmol/l

0.34

986

(3041096) Erythrocytes [Presence] in Urine by Automated

755

0.76

1.12

2.8

0.00

estimate

0.50

213

(3003458) Phosphate [Moles/volume] in Serum or Plasma

254

1.43

1.11

8.3

4.1

1.07

1.04

mmol/l

0.27

232

(3024522) Salmonella sp identified in Specimen by Organism specific culture

2.15

1.06

1.0

1.1

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

2.15

1.06

1.0

1.1

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

2.15

1.06

1.0

1.1

—

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

1.67

1.05

1.5

1.4

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

2.29

1.04

1.4

1.3

—

(3010421) pH of Blood

1.94

1.03

5.6

2.1

7.41

7.42

—

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

528

1.29

1.02

2.4

2.0

2.85

2.70

mg/l

0.18

452

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

199

1838

1.25

1.01

7.9

6.6

77.47

74.99

u/l

0.42

193

1753

(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid

2.19

0.98

1.0

1.1

—

(3035715) Granulocytes [#/volume] in Blood

1.97

0.97

1.7

3.4

4.45

3.84

e9/l

—

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

1.97

0.97

1.0

1.4

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

148

1330

1.22

0.96

6.4

4.2

6.56

6.48

mmol/l

0.20

138

1244

(3011288) Drugs identified in Urine by Screen method Nominal

109

1.59

0.96

2.8

1.7

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

0.00

0.95

0.0

1.4

—

(3024139) IgG subclass 3 [Mass/volume] in Serum

2.25

0.94

1.2

1.1

0.55

0.28

g/l

—

(4062490) Immunoglobulin typing, IgG

2.25

0.94

1.2

1.1

—

(3028192) IgG subclass 2 [Mass/volume] in Serum

2.25

0.94

1.2

1.1

3.38

2.62

g/l

—

(3027135) IgG subclass 1 [Mass/volume] in Serum

2.25

0.94

1.2

1.1

7.21

6.39

g/l

—

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

1.75

0.93

1.3

1.5

—

(3016879) Cocaine [Presence] in Urine

152

1.48

0.91

1.6

1.7

—

(3026008) Bacteria identified in Urine by Culture

602

1.26

0.90

2.8

2.6

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

103

1.58

0.89

1.8

2.2

—

(3046279) Procalcitonin [Mass/volume] in Serum or Plasma

1.93

0.89

1.1

1.3

5.67

8.22

ug/l

—

(3009343) pH of Capillary blood

120

1.53

0.87

5.3

2.5

7.39

7.42

1.58

103

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

1.84

0.86

1.4

1.5

—

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

124

1104

1.21

0.86

10.5

5.4

1.21

1.22

mmol/l

0.19

950

(1001926) Buprenorphine [Presence] in Urine by Screen method

129

1.50

0.85

1.5

1.4

—

(3009261) Glucose [Presence] in Urine by Test strip

118

1318

0.83

0.85

3.8

3.4

0.00

0.02

estimate

0.50

251

(3007164) IgA [Mass/volume] in Serum or Plasma

591

0.78

0.85

1.7

1.4

2.05

2.36

g/l

1.04

374

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

1.78

0.84

1.5

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

200

1866

1.22

0.84

4.6

3.8

12.89

9.60

mm/h

2.22

188

1750

(3025159) Blasts/Leukocytes in Blood

189

0.62

0.84

2.9

4.6

0.00

0.38

—

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

1.67

0.83

1.1

1.2

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.89

0.82

1.0

1.1

—

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.89

0.82

1.0

1.1

—

(3000764) Benzodiazepines [Presence] in Urine

165

1.43

0.80

1.7

1.6

—

(3003694) ABO and Rh group [Type] in Blood

735

0.80

1.8

1.5

—

(3021601) Nitrite [Presence] in Urine by Test strip

116

1292

0.83

0.80

3.8

3.4

0.00

estimate

-0.00

269

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.83

0.79

1.0

1.1

—

(1616796) Gas panel - Central venous blood

1.83

0.79

3.7

2.7

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

1005

0.82

0.79

3.4

3.2

0.17

0.00

estimate

0.47

226

(3028300) Cannabinoids [Presence] in Urine

166

1.42

0.78

1.7

1.6

—

(3027008) Opiates [Presence] in Urine

166

1.42

0.78

1.7

1.6

—

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

0.00

0.78

0.0

3.1

—

17.04

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

111

991

1.19

0.73

2.1

1.9

98.91

96.84

pmol/l

0.16

517

(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum

2.02

0.73

2.8

2.7

—

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

1.94

0.71

1.0

1.1

—

(46235355) HIV 1 and 2 tests - Meaningful Use set

544

1.22

0.70

2.0

2.1

—

(3008152) Bicarbonate [Moles/volume] in Arterial blood

117

0.59

0.69

10.9

5.8

27.47

24.59

mmol/l

—

111

(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay

119

0.58

0.69

1.4

2.1

—

(4195642) Thrombophilia screening test

1.68

0.69

1.3

—

(40760892) CBC W Ordered Manual Differential panel - Blood

606

0.81

0.67

3.0

3.9

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

1.80

0.66

1.4

1.3

—

(3004588) Protein electrophoresis panel - Serum or Plasma

120

1.44

0.66

2.9

2.2

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

454

1.23

0.66

1.8

1.6

—

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

246

0.71

0.66

2.0

2.1

—

(21494755) Public health laboratory ask at order entry panel

378

0.77

0.65

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

344

1.26

0.64

1.6

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

420

0.79

0.63

1.4

1.7

505.18

32143290.36

pmol/l

0.50

364

(3039443) Prostate specific Ag panel - Serum or Plasma

1.61

0.62

1.4

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

1.55

0.60

1.1

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

545

0.82

0.60

3.3

3.7

25.63

21.13

0.45

208

(3035350) Ketones [Presence] in Urine by Test strip

120

1308

0.86

0.59

3.8

3.4

0.00

5.95

estimate

0.50

273

(3018418) pH of Serum or Plasma

697

1.18

0.59

5.8

3.2

7.40

0.59

484

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

564

1.19

0.59

4.4

3.2

1431.38

808.28

ng/l

0.65

473

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

106

1.44

0.59

1.2

—

(3027944) Amphetamines [Presence] in Urine

167

1.34

0.58

1.7

1.6

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

132

1.39

0.58

1.4

—

(3014148) Varicella zoster virus Ab [Titer] in Serum

1.73

0.58

1.0

1.2

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

436

0.80

0.57

1.4

1.5

—

(3021440) Promyelocytes/Leukocytes in Blood

183

0.70

0.57

2.6

4.1

0.00

0.06

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

132

1216

1.15

0.57

3.1

2.9

105.24

95.35

ug/l

0.25

124

1152

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

247

2385

1.20

0.56

4.4

4.6

5.89

5.80

mmol/l

0.52

230

2234

(3025941) Bacteria identified in Stool by Culture

142

1.36

0.56

1.2

—

(3013139) Helicobacter pylori Ag [Presence] in Stool

181

0.71

0.54

1.2

—

(3042936) Bacteria identified in Isolate by Culture

288

1.24

0.53

2.1

1.9

—

(3022621) pH of Urine by Test strip

206

1.29

0.53

3.5

2.0

6.03

6.07

0.09

130

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

0.60

0.53

1.0

2.1

225.50

239.29

pmol/l

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

145

0.68

0.52

1.0

—

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

132

1223

1.14

0.51

5.7

5.1

9.78

10.76

umol/l

0.92

127

1161

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

199

1896

1.15

0.51

3.5

3.1

46.74

41.15

u/l

0.64

189

1833

(3017181) Myelocytes/Leukocytes in Blood

189

0.73

0.50

2.5

4.1

1.00

0.65

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

1.47

0.47

1.1

1.3

0.70

0.66

g/l

—

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

434

1.18

0.46

2.9

2.3

2.44

2.43

mmol/l

0.13

394

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

435

1.18

0.45

3.7

3.6

50.69

337.19

ng/l

1.77

299

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

434

0.83

0.45

2.9

2.7

0.68

0.67

ug/l

0.05

226

(40758558) Short blood count panel - Blood

733

1.14

0.44

8.0

5.4

—

(3038769) Chlamydophila pneumoniae IgG Ab [Units/volume] in Serum by Immunoassay

0.00

0.41

0.0

1.0

—

31.43

—

(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum

0.00

0.41

0.0

1.1

—

1816.07

—

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

0.00

0.41

0.0

1.2

—

(40768441) Liver Pathology biopsy report

0.00

0.41

0.0

1.2

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

239

2320

1.15

0.40

5.0

5.1

1.69

1.84

mu/l

0.81

225

2188

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.44

0.39

1.2

—

(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum

0.00

0.39

0.0

1.1

—

0.21

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

1.37

0.38

1.1

1.2

—

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

547

1.14

0.38

1.4

1.3

38.70

27.72

iu/ml

0.30

177

(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma

147

0.74

0.38

1.0

1.1

0.95

0.92

g/l

0.22

147

(4024509) Urine culture

1.34

0.38

2.0

1.7

—

(3049717) Cytology report of Urine Cyto stain

1.33

0.38

2.3

2.6

—

(3005570) Glucose [Moles/volume] in Urine

1.36

0.37

1.4

2.3

—

(40761536) Microorganisms panel - Urine sediment

180

1.24

0.37

2.5

3.3

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

146

0.74

0.37

1.0

1.1

1.60

1.54

g/l

0.52

146

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

821

1.12

0.36

3.6

3.2

67.00

110.86

ng/l

0.21

492

(3018095) Leukocytes [#/volume] in Urine

890

1.12

0.36

3.8

3.4

28.83

107.14

e6/l

1.48

588

(1002224) Polysomnography panel

190

1.23

0.36

1.1

—

(3019832) Treponema pallidum Ab [Presence] in Serum

312

1.17

0.35

1.8

2.0

—

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

1.40

0.35

1.2

1.0

—

(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood

0.67

0.33

1.5

—

0.01

—

(40768797) Stomach Pathology biopsy report

324

1.16

0.32

1.3

1.2

—

(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma

1.28

0.32

2.5

1.4

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

1.32

0.32

1.6

1.4

—

(3035933) Granulocytes/Leukocytes in Blood

1.35

0.31

1.7

2.8

59.00

58.40

—

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

207

0.81

0.31

1.5

2.0

—

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

114

1077

1.09

0.29

2.6

2.4

—

estimate

—

(3024889) Methemoglobin/Hemoglobin.total in Venous blood

107

0.74

0.29

3.3

2.2

0.80

0.61

—

107

(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood

109

0.73

0.29

3.3

2.2

3.14

1.40

—

109

(3018405) Lactate [Moles/volume] in Arterial blood

1.30

0.28

5.0

4.4

1.25

1.36

mmol/l

—

(43054914) Glucose tolerance 2 hours panel - Serum or Plasma

291

1.15

0.27

1.8

1.7

—

(40762366) Oxygen capacity [Volume Fraction] in Arterial blood

104

1.26

0.27

13.5

9.8

16.12

16.38

0.13

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

203

0.83

0.26

1.2

1.3

49.67

151.10

u/ml

—

(3037467) Urinalysis macro (dipstick) panel - Urine

161

1670

0.92

0.26

4.7

3.8

—

4.90

—

(3002582) Erythrocytes [#/volume] in Urine

747

1.10

0.26

3.5

2.8

32.83

58.31

e6/l

0.57

550

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

718

1.10

0.26

2.5

2.2

81.79

71.18

u/l

0.13

669

(3044889) 12 lead EKG panel

178

1721

1.08

0.26

3.6

3.5

—

0.17

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

1.21

0.25

1.0

1.2

—

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

249

2533

0.90

0.24

4.6

4.8

4.78

4.75

mmol/l

0.21

236

2409

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

0.73

0.24

1.2

1.1

—

(4034850) Laboratory test

0.72

0.24

3.3

8.2

—

(3014576) Chloride [Moles/volume] in Serum or Plasma

275

1.14

0.24

15.3

5.8

103.68

104.10

mmol/l

0.20

275

(3009508) Creatinine [Moles/volume] in Urine

790

1.09

0.24

3.5

3.1

7.35

8.23

mmol/l

1.21

684

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

235

2396

0.91

0.24

4.0

1.35

1.31

mmol/l

0.42

222

2253

(3037756) Immunofixation for Serum or Plasma

1.32

0.23

3.4

1.5

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

270

2664

1.14

0.23

11.2

9.9

27.59

27.81

u/l

0.08

262

2618

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

0.76

0.23

1.6

—

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

1.25

0.22

1.2

—

(4268621) Lupus anticoagulant assay

1.25

0.22

2.4

2.3

—

(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma

1.25

0.22

1.6

2.6

8.44

6.99

pmol/l

—

(3021960) Folate [Moles/volume] in Serum or Plasma

624

0.91

0.22

1.7

1.6

21.11

22.07

nmol/l

0.18

540

(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum

0.00

0.21

0.0

1.5

—

8.65

—

(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline

0.00

0.21

0.0

1.2

—

7.47

—

(42529582) MDA5 Ab [Presence] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum

0.00

0.21

0.0

1.1

—

51.17

—

(3013637) Mi-2 Ab [Presence] in Serum

0.00

0.21

0.0

1.0

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.5

—

64.40

—

(3036071) Salmonella sp Ab [Titer] in Serum

0.00

0.21

0.0

1.2

—

(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification

0.00

0.21

0.0

11.6

—

32.57

—

(3004451) EKG impression Narrative

0.00

0.21

0.0

1.5

—

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

0.00

0.21

0.0

1.4

—

(3000494) Fungus identified in Specimen by Culture

302

0.88

0.20

1.4

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.0

—

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.0

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

0.20

0.0

1.0

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

0.00

0.20

0.0

1.0

—

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

1.23

0.20

2.5

1.4

—

(3002385) Erythrocyte [DistWidth] in Red Blood Cells

214

2183

0.93

0.19

19.9

14.4

13.46

13.41

0.25

209

2165

(3015171) Extractable nuclear Ab [Units/volume] in Serum

119

1.19

0.18

1.1

1.2

—

1.47

—

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

249

2524

0.92

0.17

4.6

4.7

1.45

1.46

mmol/l

0.13

237

2393

(3030467) Casts [#/volume] in Urine by Automated count

644

1.07

0.17

3.6

2.6

0.31

0.39

e6/l

0.21

454

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

185

1809

1.06

0.16

3.4

—

(3020564) Creatinine [Moles/volume] in Serum or Plasma

268

2652

1.10

0.16

19.2

14.4

74.88

74.09

umol/l

0.12

268

2627

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

197

1.13

0.16

1.4

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.77

0.16

1.8

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.76

0.15

2.0

1.5

1.11

1.23

ratio

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.76

0.15

2.0

1.5

1.12

ratio

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.76

0.15

2.0

1.5

0.83

0.95

ratio

—

(40768804) Tissue Pathology biopsy report

977

0.94

0.15

2.0

—

(3030981) Hyaline casts [#/volume] in Urine by Automated count

181

0.88

0.14

1.9

2.2

0.11

0.67

e6/l

0.61

172

(4094501) Cardiovascular stress test using bicycle ergometer

1.20

0.14

1.0

1.1

—

(3029937) Albumin [Presence] in Urine by Test strip

681

0.94

0.13

3.9

3.6

0.05

0.00

estimate

0.43

251

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

366

1.08

0.12

3.5

2.6

2.24

1.78

e6/l

0.16

161

(40768443) Skin Pathology biopsy report

1.16

0.12

1.1

—

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

289

1.08

0.11

1.8

4.24

3.53

mmol/l

1.84

217

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

397

1.07

0.11

3.5

2.4

1.19

0.91

e6/l

0.39

191

(40761511) CBC panel - Blood by Automated count

259

2612

0.94

0.10

12.4

10.1

—

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

1.11

0.10

1.0

1.1

—

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

1.09

0.09

1.0

1.1

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

1.06

0.09

1.2

1.1

—

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

242

2397

1.05

0.09

14.6

11.1

88.49

86.72

ml/min/173m2

0.68

227

2191

(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma

1.11

0.09

2.0

1.6

—

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

1.09

0.09

1.0

1.1

—

19.04

—

(40768793) Breast Pathology biopsy report

0.77

0.08

1.0

1.3

—

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

0.85

0.07

1.5

1.6

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

248

2499

0.96

0.07

17.5

11.1

25.23

20.30

mg/l

1.60

217

1963

(44816559) Phosphatidylethanol [Mass/volume] in Blood

137

1.10

0.07

1.7

1.6

0.21

0.32

mg/l

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

147

1.09

0.07

1.9

2.4

2.76

8.51

ug/l

—

132

(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay

0.86

0.07

1.1

—

2.70

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

0.85

0.07

1.1

—

(42529406) Shigella sp [Presence] in Stool by Culture

0.84

0.07

1.1

—

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

1.07

0.07

1.2

1.3

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

1.06

0.07

1.2

1.3

—

8.49

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

1.06

0.07

2.0

1.7

66.86

60.98

ug/l

—

(3019060) Gas panel - Arterial blood

102

0.88

0.06

4.7

3.4

—

(36660697) Celiac disease serology panel - Serum

228

1.06

0.05

1.0

1.2

—

(3002256) Pathology report gross observation

302

0.96

0.04

1.2

—

(3019150) Specific gravity of Urine by Refractometry

574

0.97

0.04

3.9

3.5

1.02

kg/l

0.22

370

(3003327) Ova and parasites identified in Stool by Light microscopy

1.10

0.04

1.5

1.6

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

197

1958

1.02

0.03

4.2

14.59

14.63

pmol/l

0.10

185

1833

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

109

1078

1.02

0.03

2.7

2.5

73.92

76.83

nmol/l

0.55

990

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

420

1.03

0.03

2.1

2.3

—

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

255

2559

0.98

0.02

5.1

5.3

2.82

2.83

mmol/l

0.11

244

2424

(3050129) First trimester maternal screen panel - Serum or Plasma

1.08

0.02

1.8

1.5

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

392

1.02

0.01

2.2

2.0

4.16

3.57

ratio

1.13

316

(3037522) Nuclear Ab [Titer] in Serum

402

1.02

0.01

1.4

600.00

633.71

titre

—

(3048689) Calprotectin [Mass/mass] in Stool

367

0.98

0.01

2.5

92.08

94.24

ug/g

0.03

304

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

493

1.02

0.01

1.5

1.3

5.44

8.59

u/ml

0.32

198

(3004716) Salmonella sp identified in Stool by Organism specific culture

156

0.96

0.00

1.1

1.3

—

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

384

1.02

0.00

2.1

2.2

—

(3008898) HLA-B27 [Presence]

142

0.99

0.00

1.1

—

(4035726) Immunohistochemistry procedure

171

0.99

0.00

1.7

1.4

—

(3021879) Hepatitis B virus core Ab [Presence] in Serum

209

1.01

0.00

1.2

1.5

—

(3007461) Platelets [#/volume] in Blood

276

2761

1.00

0.00

23.9

17.8

257.53

254.74

e9/l

0.26

270

2725

(3000492) Spirometry study

301

1.00

0.00

1.2

1.4

—

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

234

2343

0.99

0.00

5.6

5.5

38.64

38.43

mmol/mol

0.13

225

2249

(3020682) Albumin/Creatinine [Ratio] in Urine

696

1.01

0.00

4.4

3.9

18.55

6.69

mg/mmol

0.46

442

(3001019) Free T4 and TSH panel - Serum or Plasma

176

1.02

0.00

1.2

1.8

—

(3026361) Erythrocytes [#/volume] in Blood

276

2764

0.98

0.00

23.8

17.7

4.51

4.61

e12/l

2.50

270

2721

(3010813) Leukocytes [#/volume] in Blood

276

2764

0.98

0.00

23.8

17.8

6.80

6.54

e9/l

1.45

270

2719

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

606

1.01

0.00

1.7

1.6

—

(3022145) Colonoscopy Study observation

286

1.02

0.00

1.6

1.4

—

(3012516) Albumin [Mass/volume] in Urine

695

0.99

0.00

3.8

3.3

66.99

39.02

mg/l

0.33

454

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

0.90

0.00

1.0

1.2

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

0.93

0.00

3.7

2.9

9.14

725.32

u/ml

—

(3014043) Spermatozoa Nonprogressive/Spermatozoa in Semen

0.00

-0.00

0.0

6.9

—

8.57

—

(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture

0.95

-0.00

1.0

1.5

—

(3032567) Hepatitis B virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

0.00

-0.00

0.0

3.0

—

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

0.00

-0.00

0.0

3.2

—

(3015736) pH of Urine

106

1060

1.00

-0.00

3.3

3.1

6.23

6.17

0.22

625

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

-0.00

0.0

2.0

—

(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay

0.00

-0.00

0.0

1.2

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

-0.00

0.0

1.8

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(3017704) Immunofixation for Urine

0.00

-0.00

0.0

1.0

—

(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma

0.00

-0.00

0.0

2.0

—

4.18

—

(3041806) Other cells [#/volume] in Blood by Manual count

0.00

-0.00

0.0

1.0

—

0.48

—

(3020650) Glucose [Presence] in Urine

0.00

-0.00

0.0

1.5

—

0.00

—

(3016038) Potassium [Moles/volume] in Urine

0.00

-0.00

0.0

1.1

—

29.25

—

(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.0

—

4.42

—

(3048929) Epstein Barr virus Ab [Presence] in Serum

1.01

-0.00

2.0

1.2

—

(3006462) Nitrate [Presence] in Urine

0.00

-0.00

0.0

1.1

—

(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma

0.00

-0.00

0.0

1.5

—

14.67

—

(3002619) Bacteria identified in Specimen by Culture

0.00

-0.00

0.0

1.1

—

(3028717) Thiamine [Mass/volume] in Blood

0.00

-0.00

0.0

1.6

—

60.14

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

1.02

-0.00

1.4

1.3

—

(40761995) Spermatozoa Progressive [#/volume] in Semen

0.00

-0.00

0.0

3.4

—

47.14

—

(3022689) Creatine [Moles/volume] in Urine

0.00

-0.00

0.0

1.3

—

12.61

—

(3011897) Casein IgE Ab [Units/volume] in Serum

0.00

-0.00

0.0

1.2

—

0.35

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

1.8

—

11.41

—

(3028626) Oxygen [Partial pressure] in Capillary blood

1.00

-0.00

1.8

2.6

7.98

8.68

kpa

—

(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay

0.00

-0.00

0.0

1.2

—

(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum

110

1.00

-0.00

1.0

1.3

47.33

274.42

miu/ml

—

(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

0.89

-0.00

1.3

—

0.96

—

(42870325) Hepcidin 25 amino acid peptide [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

2.8

—

5.50

—

(3043409) Potassium [Moles/volume] in Arterial blood

0.94

-0.00

7.2

3.5

4.06

3.85

mmol/l

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

0.00

-0.00

0.0

1.8

—

4.55

—

(3024932) HLA-DR beta [Type]

0.00

-0.00

0.0

1.0

—

(3024471) HLA-A [Type]

0.00

-0.00

0.0

1.0

—

(4211845) Urine protein measurement

0.00

-0.00

0.0

1.1

—

(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection

0.00

-0.00

0.0

1.3

—

(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection

0.00

-0.00

0.0

1.0

—

(40765096) Chromosome analysis panel by Banding

0.00

-0.00

0.0

1.1

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

0.00

-0.00

0.0

1.0

—

(3025130) Human papilloma virus identified in Specimen

0.96

-0.00

1.6

1.8

—

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

0.00

-0.00

0.0

1.0

—

Mortality – FinRegistry

↥

Association

Association between endpoint AB1_MENINGOCOCCAL and mortality.

Females

Parameter	HR [95% CI]	p-value
AB1_MENINGOCOCCAL	2.491 [1.73, 3.59]	< 0.001
Birth year	0.997 [0.99, 1.01]	0.475

During the follow-up period (1.1.1998 — 31.12.2019), 101 out of 463 females with AB1_MENINGOCOCCAL died.

Males

Parameter	HR [95% CI]	p-value
AB1_MENINGOCOCCAL	2.574 [1.72, 3.86]	< 0.001
Birth year	0.989 [0.98, 1.0]	0.054

During the follow-up period (1.1.1998 — 31.12.2019), 82 out of 513 males with AB1_MENINGOCOCCAL died.

Mortality risk

Mortality risk for people of age

years, who have AB1_MENINGOCOCCAL.

N-year risk	Females	Males
1	0.184%	0.429%
5	1.429%	2.889%
10	3.829%	7.419%
15	7.655%	14.077%
20	13.33%	23.471%

Relationships between endpoints

↥

Index endpoint: AB1_MENINGOCOCCAL – Meningococcal infection

GWS hits: -

Endpoint

Case Overlap

Survival Analysis

Genetic Correlations

Genetic Signals

N (Jaccard index)

HR [CI]

rg [CI]

Hits

Coloc Hits

FinRegistry

FinnGen

FinRegistry

FinnGen

Loading data

Meningococcal infection

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

Similar endpoints

Case counts by codes

Summary Statistics

-FinRegistry-

Key figures

-FinnGen-

Key figures

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Association

Females

Males

Mortality risk

Relationships between endpoints